Astellas

Based in Tokyo, Astellas is widely regarded as one of Japan's flagship pharmaceuticals operators. Its scale — about 14k people, around $11B in turnover — translates into genuine strategic weight across Asia Pacific.

Digital reinvention is no longer a marketing line: it is reshaping unit economics across customer acquisition, supply chain and after-sales.

“Astellas is, in its category, exactly the kind of compounding regional champion the next decade of capital allocation will reward.”

Analysts increasingly view the group as a regional bellwether — its quarterly trajectory tends to anticipate sector-wide moves.